Rachel Lutz

The main cause of C. difficile is antibiotics, not hospital conditions.

The study was the largest of MS patients treated with rituximab to date.

Diabetes shortens life by years, study found.

Texts, phone reminders are good medicine in diabetes.

A study finds that massages may improve fatigue, pain symptoms in MS patients.

Diabetes: trained dogs monitor glucose levels.

C. diff infections appear to lurk in long-term acute care facilities.

C. diff guideline highlights the need for international agreement.

Patients using fidaxomicin for C diff infection experienced no recurrences..

Researchers, for the first time, used the lyophilized non-frozen oral capsule RBX7455 to treat a patient with recurrent Clostridium difficile (C. difficile) infection.

People with multiple sclerosis tend to have sleep apnea, but not the usual kind, a study found.

There is an urgent need to improve diagnostic abilities and management of borderline personality disorder, despite significant breakthroughs.

Looking at post-mortem brain samples, researchers found that multiple sclerosis is associated with an abundance of bacteria and molecular diversity.

While effective for Clostridium difficile (C. difficile) infection in irritable bowel syndrome (IBS) patients, fecal microbiota transplants did not relieve the IBS itself.

Finding neural stem cells in the brain’s meninges could lead to new therapies for multiple sclerosis patients.

Alemtuzumab was more beneficial to patients with relapsing remitting multiple sclerosis than subcutaneous interferon beta 1a in various measures of preexisting disability.

Many off label therapeutic options currently exist for treating Clostridium difficile (C. difficile) infection, but combinations of these choices can develop into viable, approved treatments, according to a recently published product review.

Traces of Clostridium difficile bacteria are occasionally found in the final products of manure compost and can even transfer C. difficile into the food chain.

Physicians have long been concerned that patients with multiple sclerosis who get frequent brain scans accumulate deposits of the rare earth used as a contrast agent, gadolinium. German researchers found an alternative agent.

The nonprofit, Institute for Clinical and Economic Review, is preparing a set of recommendations on best drugs for multiple sclerosis and is seeking public comment.

According to new research, fecal transplantations were just as effective as the standard Clostridium difficile (C. difficile) treatment, oral vancomycin taper, in patients with recurrent C. difficile infections.

A signaling mechanism can turn T-cells into destroyers.

Cornell scientists said they created a chemical tool that uses ultraviolet light to track inflammation and even control it. Their hope is it might work to treat inflammatory diseases, perhaps even multiple sclerosis.

In a letter, the Textile Rental Services Association strongly responded to the article. David F. Goldsmith, MSPH, PhD, wrote that the story on hospital laundry facilities could “misleadingly create false alarms.”

It may be possible to boost social interaction in people with autism by using a new therapeutic drug target, University of Pennsylvania researchers say.

Despite the fact that two thirds of stroke survivors could suffer from a visual impairment, nearly half of stroke units do not even assess vision. A recent report suggests that more must be done to assess the outlook for vision in stroke survivors.

Simple diagnostic tools like yes-or-no questions lack the nuance required to keep autistic children from being misdiagnosed with attention deficit hyperactivity disorder, according to a new report from the Children's Hospital of Philadelphia.

Between 2012 and 2014, 19 Pomona Valley patients died from C. difficile infection. One environmental services employee quoted in the LA Times said that she had not received any training on infection control in her 12 years of employment there.

A team was able to demonstrate that spinal cord injury causes the relocation of some of the gut’s bacteria from sterile tissues to other locations throughout the body, and it appeared that these changes were linked to the activation of the immune system cells in the gut.

It is reportedly safe to use tissue plasminogen activator, the clot busting medication, on patients who wake up with symptoms of stroke, according to a new study. Generally, tPA should be administered within 4.5 hours of symptom onset to be considered effective.